JCTeD Bridge Accelerator Program

Objective

The Joint Centre for Technology and Development (JCTeD) is calling all Researchers, Clinicians, Inventors, and Innovators from the SingHealth Duke-NUS Academic Medical Centre to fast-track your research, education or innovation project for commercialisation by joining this Joint Centre for Technology and Development’s inaugural Bridge Accelerator Program.

JCTeD is the one-stop commercialisation resource centre for the SingHealth Duke-NUS Academic Medical Centre (AMC). JCTeD supports researchers, clinicians, inventors, and innovators across the AMC by identifying commercialisation pathways and facilitating access to funding, expertise, and development resources for health, life sciences, and biomedical technologies with high commercial potential.

JCTeD is a collaboration between the SingHealth Intellectual Property (SHIP) office and the Duke-NUS Centre for Technology and Development (CTeD) and its mission is to create health and economic impact by supporting innovation, entrepreneurship, and the commercialisation of research at the AMC.

JCTeD Bridge Accelerator Program　
The unique mentoring and funding support provided by the Bridge Accelerator Program will strengthen the commercial proposition of your research innovation. The program supports innovations in any technology space relevant to health including (but not limited to) therapeutics, diagnostics, preventives, devices, digital and data innovations, and enterprise solutions.

Your project should have the potential to improve health outcomes, enhance healthcare delivery, or deliver cost-savings in healthcare systems, and should be at a stage of development where you have some evidence that it works. The Bridge Accelerator Program will help you validate, and advance, your project’s commercial merit.

The JCTeD Bridge Accelerator Program will provide input from industry and investor professionals, and fund commercialisation services to position and strengthen your technology’s potential for translational funding or industry partnership, or commercialisation via licensing to an established company or a new venture. The business support will be heavily tailored to the technology, its respective stage of development, and its commercial potential.

Funding Details

1. Funding per award is capped at S$50,000 for a period of 1 year.
2. Funding to be used for commercialisation services and support.
3. Additional support:

• • Feedback and guidance from investors and industry professionals
  • Providing guidance in applying for third party translational funding programs from NHIC, SMART, STDR etc.

Note:

• Should you be unclear of what support is needed, JCTeD representatives will be able to work together with the team to create a program that will set goals, milestones and metrics.
• • Some examples of the type of support that the Bridge Accelerator Program may support for an innovation project include, but are not limited to:
  • • Contract research organizations for specific materials/data development needed for commercialisation;
    • Entrepreneur-in-Residence to drive the commercialisation;
    • Development of a business plan, financial modeling, pitch decks, business development;
    • Specialist professional advice including for regulatory, manufacturing or other planning.

Eligibility Criteria

1. The applicant must be an employee of SingHealth or Duke-NUS.
2. Though not required, collaborative projects between SingHealth and Duke-NUS will be viewed favorably.
3. Projects must have commercial potential:

• • The team should have made (or be ready to make) an invention disclosure to either SingHealth and/or Duke-NUS, and/or
  • There must be a mechanism for a commercial outcome, such as a license or startup/spinout.
  • In some cases, to receive funds from the JCTeD Bridge Accelerator Program, your institution may need to provide matching funds. This requirement depends on yours and your collaborators' institutional affiliations.

Note:

• Interested Duke-NUS investigators who are unsure whether they meet the eligibility criteria, please approach CTeD at cted@duke-nus.edu.sg before submission.
• Exploratory and basic research and technology development is outside the scope of the Bridge Accelerator program.

Submission

1. Interested applicants are to submit the completed application form 'JCTeD BAP - Proposal Template_2023’ through your Host Institution's Research office to SHIP at SHIP@singhealth.com.sg or CTeD at cted@duke-nus.edu.sg by 30th November 2023 (Thursday), 5pm.

2. JCTeD representatives will work with applicants to ensure that their pre-proposals are well-positioned for consideration (including preparing an invention disclosure if needed).
3. Shortlisted applicants will be invited to work with JCTeD representatives to prepare and present a project pitch to a JCTeD panel of internal and external commercialisation experts and investors.

Note:

• No endorsement is required.
• SingHealth PIs are to please refer to your respective Institutional Research Administrators for guidance on internal deadlines and submission procedures set by your institutions.

Contact Person

Email: SHIP@singhealth.com.sg

OR

Email: cted@duke-nus.edu.sg

Additional Information

JCTeD BAP - Proposal Template_2023.docx

JCTeD Bridge Accelerator Program.pdf